Register

GLP-1s forced a high-profile reckoning with an uncomfortable question in health care: What do you do when a medication works, but you can’t give it to everyone who needs it?

As chronic disease rates climb and specialty drugs arrive with exorbitant price tags, physicians are increasingly asked to balance high-quality care against financial realities. It’s a conversation happening in boardrooms and exam rooms across the country.

Join the webinar to learn about:

• How preventive, value-based care can help reduce rising medication costs
• The role biosimilars could play in improving outcomes while controlling costs
• What GLP-1s reveal about whether value-based care can transform pharmacy policy, access, and affordability

Featuring:

• Peter J. Neumann, ScD, director, Center for the Evaluation of Value and Risk in Health, Tufts University
• Maisha Draves, MD, MPH, associate executive director, The Permanente Medical Group
• Stephen Parodi, MD, executive vice president, The Permanente Federation (moderator)

This is a free live webinar. Can’t watch live? Register now and we’ll send you the recording afterward.

Register